Clinical trialObservationalRecruiting
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
- Outcome
- Ongoing
- Phase
- Observational
- Status
- Recruiting
- Study type
- Observational
- Start
- 1 September 2017
- Expected end
- 30 April 2030
- Enrollment
- 500 participants
- Sites
- 1
- Primary outcomes
- Pancreas Cancer
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 1 April 2025
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.
Detailed description public domain (ClinicalTrials.gov)
Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer. 1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol. 2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.
Intervention public domain (ClinicalTrials.gov)
Diagnostic_Test: Bio-Specimen Collection. Collection of bio-specimens and observation over time.
Arm public domain (ClinicalTrials.gov)
Pancreatic Cysts (): Patients with pancreatic cyst undergoing endoscopic ultrasound and/or surgery who will have bio-specimens collected
Arm public domain (ClinicalTrials.gov)
High Risk Individuals (): Patients with established family history and/or genetic mutations for Pancreas cancer who will have bio-specimens collected
Primary outcome public domain (ClinicalTrials.gov)
Pancreas Cancer. Development of Pancreas Cancer Time frame: 5-10 years.
Eligibility public domain (ClinicalTrials.gov)
Inclusion Criteria: * Older than 18 with pancreas cyst * Older than 18 at high risk for Pancreas cancer Exclusion Criteria: * Unable to provide consent * Not willing to provide bio-specimens
Enrollment public domain (ClinicalTrials.gov)
Enrollment: 500 participants (estimated).